Skip to content

the Evaluation of the Efficacy of TCI66207 on the Skin.

Evaluation of Skin Efficacy of TCI66207

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05143034
Enrollment
40
Registered
2021-12-03
Start date
2018-11-01
Completion date
2019-12-31
Last updated
2021-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Diseases

Brief summary

The purpose of this study is to explore the evaluation of the efficacy of TCI66207 deep-sea live-face bacteria on the skin.

Interventions

DIETARY_SUPPLEMENTTCI66207 Essence

Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.

DIETARY_SUPPLEMENTPlacebo Essence

Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy volunteers aged above 20 years old 2. Subject has dull skin.

Exclusion criteria

1. .Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history). 2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder. 3. Female who is pregnant or nursing or planning to become pregnant during the course of the study. 4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks. 5. Subjects who have large spots (area \>3 square centimeter) or abnormal acne.

Design outcomes

Primary

MeasureTime frameDescription
The change of skin moistureSubjects will be tested in the 4th week.Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120
The change of skin elasticitySubjects will be tested in the 4th week.Cutometer® dual MPA 580 was utilized to measure skin elasticity (parameter R2). Units: μm penetration depth into the probe opening, expressed as curvesCorneometer® units 0-120
The change of skin wrinklesSubjects will be tested in the 4th week.VISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units
The change of skin collagen densitySubjects will be tested in the 4th week.DermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units: Intensity score
The change of skin textureSubjects will be tested in the 4th week.VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin poresSubjects will be tested in the 4th week.VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026